These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26503817)

  • 41. [Changes of CYP2E1 activity in diabetic rat model].
    Li L; Zhang Y
    Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship in healthy subjects between CYP2E1 genetic polymorphisms and the 6-hydroxylation of chlorzoxazone: a putative measure of CYP2E1 activity.
    Kim RB; O'Shea D; Wilkinson GR
    Pharmacogenetics; 1994 Jun; 4(3):162-5. PubMed ID: 7920697
    [No Abstract]   [Full Text] [Related]  

  • 44. Selective Time- and NADPH-Dependent Inhibition of Human CYP2E1 by Clomethiazole.
    Stresser DM; Perloff ES; Mason AK; Blanchard AP; Dehal SS; Creegan TP; Singh R; Gangl ET
    Drug Metab Dispos; 2016 Aug; 44(8):1424-30. PubMed ID: 27149898
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-alpha.
    Liu H; Jones BE; Bradham C; Czaja MJ
    Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G257-66. PubMed ID: 11804847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans.
    Doroshyenko O; Fuhr U; Kunz D; Frank D; Kinzig M; Jetter A; Reith Y; Lazar A; Taubert D; Kirchheiner J; Baum M; Eisenbrand G; Berger FI; Bertow D; Berkessel A; Sörgel F; Schömig E; Tomalik-Scharte D
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):433-43. PubMed ID: 19190172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relative impact of nucleotide and copy number variation on gene expression phenotypes.
    Stranger BE; Forrest MS; Dunning M; Ingle CE; Beazley C; Thorne N; Redon R; Bird CP; de Grassi A; Lee C; Tyler-Smith C; Carter N; Scherer SW; Tavaré S; Deloukas P; Hurles ME; Dermitzakis ET
    Science; 2007 Feb; 315(5813):848-53. PubMed ID: 17289997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5.
    Wiercinska P; Squires EJ
    Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P4502E1 phenotyping by the measurement of the chlorzoxazone metabolic ratio: assessment of its usefulness in workers exposed to styrene.
    Haufroid V; Buchet JP; Gardinal S; Lison D
    Int Arch Occup Environ Health; 2002 Sep; 75(7):453-8. PubMed ID: 12172891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trimethadione metabolism by human liver cytochrome P450: evidence for the involvement of CYP2E1.
    Kurata N; Nishimura Y; Iwase M; Fischer NE; Tang BK; Inaba T; Yasuhara H
    Xenobiotica; 1998 Nov; 28(11):1041-7. PubMed ID: 9879636
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic inference of copy-number genotypes from personal genome sequencing data reveals extensive olfactory receptor gene content diversity.
    Waszak SM; Hasin Y; Zichner T; Olender T; Keydar I; Khen M; Stütz AM; Schlattl A; Lancet D; Korbel JO
    PLoS Comput Biol; 2010 Nov; 6(11):e1000988. PubMed ID: 21085617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CYP2E1 hydroxylation of aniline involves negative cooperativity.
    Hartman JH; Knott K; Miller GP
    Biochem Pharmacol; 2014 Feb; 87(3):523-33. PubMed ID: 24345333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism.
    Lee AM; Joshi M; Yue J; Tyndale RF
    Eur J Pharmacol; 2006 Dec; 552(1-3):151-8. PubMed ID: 17049344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytochrome P450 2E1 expression induces hepatocyte resistance to cell death from oxidative stress.
    Jones BE; Liu H; Lo CR; Koop DR; Czaja MJ
    Antioxid Redox Signal; 2002 Oct; 4(5):701-9. PubMed ID: 12470497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.
    Kim RB; Yamazaki H; Chiba K; O'Shea D; Mimura M; Guengerich FP; Ishizaki T; Shimada T; Wilkinson GR
    J Pharmacol Exp Ther; 1996 Oct; 279(1):4-11. PubMed ID: 8858968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of methacrylonitrile on cytochrome P-450 2E1 (CYP2E1) expression in male F344 rats.
    Wang H; Chanas B; Ghanayem BI
    J Toxicol Environ Health A; 2002 Apr; 65(7):523-37. PubMed ID: 11939710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mammalian PC-12 cell genetically engineered for human cytochrome P450 2E1 expression.
    Mapoles J; Berthou F; Alexander A; Simon F; Ménez JF
    Eur J Biochem; 1993 Jun; 214(3):735-45. PubMed ID: 8391436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The investigation into CYP2E1 in relation to the level of response to alcohol through a combination of linkage and association analysis.
    Webb A; Lind PA; Kalmijn J; Feiler HS; Smith TL; Schuckit MA; Wilhelmsen K
    Alcohol Clin Exp Res; 2011 Jan; 35(1):10-8. PubMed ID: 20958328
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation.
    Burckart GJ; Frye RF; Kelly P; Branch RA; Jain A; Fung JJ; Starzl TE; Venkataramanan R
    Clin Pharmacol Ther; 1998 Mar; 63(3):296-302. PubMed ID: 9542473
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of cytochrome P4502E1 (CYP2E1) activity and hepatic and lymphocyte mRNA expression in patients with chronic hepatitis C.
    Haufroid V; Ligocka D; Wallemacq P; Lison D; Horsmans Y
    Toxicol Lett; 2005 Jan; 155(1):171-7. PubMed ID: 15585372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.